[{"Assets_0_Q2_USD":494245000.0,"CommonStockSharesOutstanding_0_Q2_shares":53499057.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-80119000.0,"NetIncomeLoss_1_Q2_USD":-53699000.0,"NetIncomeLoss_2_Q2_USD":-102107000.0,"StockholdersEquity_0_Q2_USD":367683000.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190729"}]